Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2026-02-23 @ 8:08 PM
Study NCT ID:
NCT02489903
Status:
COMPLETED
Last Update Posted:
2025-03-17
First Post:
2015-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Sponsor:
EpicentRx, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RRx001-211-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None